Global Peptide Therapeutics Competitive Landscape Professional Research Report 2024

Global Peptide Therapeutics Competitive Landscape Professional Research Report 2024

Research Summary

Peptide therapeutics are a class of pharmaceutical drugs composed of short chains of amino acids, known as peptides, that are designed to target specific biological molecules or pathways to treat various medical conditions and diseases. These therapeutic peptides can mimic the activity of natural peptides or proteins in the body, regulate or inhibit certain biochemical processes, and interact with specific receptors or enzymes. They are highly precise and often have fewer side effects compared to traditional small-molecule drugs. Peptide therapeutics have been developed for a wide range of medical applications, including treating cancer, diabetes, autoimmune disorders, infectious diseases, and more. Due to their specificity and effectiveness, peptide-based drugs have gained significant attention in the pharmaceutical industry, and ongoing research and development continue to expand the use of peptide therapeutics for various healthcare needs.

According to DIResearch's in-depth investigation and research, the global Peptide Therapeutics market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Peptide Therapeutics include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, Johnson & Johnson etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Peptide Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peptide Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Peptide Therapeutics Include:

Sanofi

Teva

Novo Nordisk

Takeda

Eli Lilly

AstraZeneca

Novartis

AbbVie

Ipsen

Ferring

Merck

The Medicines

Johnson & Johnson

Peptide Therapeutics Product Segment Include:

Injection

Oral

Others

Peptide Therapeutics Product Application Include:

Cancer

Metabolic Disorders

Central Nervous System

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Peptide Therapeutics Industry PESTEL Analysis

Chapter 3: Global Peptide Therapeutics Industry Porter’s Five Forces Analysis

Chapter 4: Global Peptide Therapeutics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Peptide Therapeutics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Peptide Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources